Agarwal, Shrishti, and Sanchit Mehta. 2024. “Food and Drug Administration Gives Breakthrough: Sanctioning of Rezdiffra for Non-Alcoholic Steatohepatitis”. International Journal of Advances in Medicine 12 (1):155-55. https://doi.org/10.18203/2349-3933.ijam20243826.